Are pharmacogenetic biomarkers (SNPs in CYP2D6, CYP2C19, TPMT) analyzed for every cancer patient before prescribing medications?

Pharmacogenetics biomarkers (such as CYP2D6, CYP2C19, TPMT) are suggested to be used before prescribing and deciding about the dosage of drugs, especially for cancer chemotheraphy. I was...

03 March 2018 6,723 3 View